Pradžia › Meduloblastoma › Florida
Meduloblastoma klinikiniai tyrimai Florida
6 tyrimai dėl Meduloblastoma ieško dalyvių vietose Florida.
Miestai Florida
Oficialus tyrimo tekstas (anglų kalba)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Orlando Health Arnold Palmer Hospital for Children, Orlando
- St. Joseph's Children's Hospital, Tampa
Renkami dalyviai2 fazė
59 Months · Visoms lytims · Atnaujinta 2026-09-15 · NCT05535166Digoxin Medulloblastoma Study
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- Johns Hopkins All Children's, St. Petersburg
- ir dar 1
Renkami dalyviai2 fazė
12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-08-26 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- Nemours Children's Clinic-Jacksonville, Jacksonville
- ir dar 7
Renkami dalyviai3 fazė
Amžius nuo 4 iki 21 · Visoms lytims · Atnaujinta 2026-08-25 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Nicklaus Children's Hospital, Miami
Renkami dalyviai2 fazė
Amžius nuo 3 iki 39 · Visoms lytims · Atnaujinta 2026-08-24 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- All Children's Hospital Johns Hopkins Medicine, St. Petersburg
- ir dar 1
Renkami dalyviai2 fazė
Iki 21 metų · Visoms lytims · Atnaujinta 2026-08-12 · NCT04696029Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- University of Florida Health, Gainesville
Renkami dalyviai1 fazė
Amžius nuo 4 iki 30 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06514898Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.